Published in:
Open Access
01-12-2019 | Human Immunodeficiency Virus | Research Letter
Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
Authors:
Jonathan Rilinger, Dawid L. Staudacher, Siegbert Rieg, Daniel Duerschmied, Christoph Bode, Tobias Wengenmayer
Published in:
Critical Care
|
Issue 1/2019
Login to get access
Excerpt
Pneumocystis jirovecii pneumonia (PJP) is a severe complication of immunosuppression that is associated with high mortality, depending on the underlying type of immunosuppression [
1]. Consequently, the incidence of PJP is higher in non-HIV patients than in HIV patients, because of the increased use of immunosuppressive therapies for widespread indications [
2]. So far, there is little evidence for veno-venous extracorporeal membrane oxygenation (ECMO) treatment in cases of PJP-induced severe acute respiratory distress syndrome (ARDS). Particularly, there is no study reporting and comparing the outcome of PJP requiring ECMO therapy in HIV and non-HIV patients. …
